DCX Systems has received contracts/orders for Rs 107.09 crore from Domestic and Overseas Customers. The orders are for supply of electronic kits and cable & wire harness assemblies. The order is to be executed within 12 months.
Panabyte Technologies has received a contract work order of Attendance Monitoring Access Control System at Mangalore Refinery & Petrochemicals under the Materials Department, Ministry of Petroleum and Natural Gas. Broad consideration or size of the order is Rs 1.99 crore.
Sam lndustries has entered into a lease agreement with Instakart Services on August 16, 2024, for providing warehouse on lease to Instakart services. Lease Agreement is for providing warehouse on lease for nine years with lock in period of three years.
Jyothi Infraventures has received approval for acquisition of 100% of the Share Capital of Mizzen Digital (Target Company). The Board has approved the execution of a Share Purchase and Share Subscription Agreement (SPSSA) other necessary documents regarding the Proposed Transaction between the Company, Target Company and the shareholders of Target Company, whereby the Company agrees to acquire 100% of the share capital of the target company.
Panabyte Technologies has received a contract work order from one of the laboratories under the Department of Defence Research & Development (DRDO), Ministry of Defence, Government of India, to carry out Procurement, Installation and Commissioning of Human and Vehicle Access Control. Broad consideration or size of the order is Rs 2.62 crore.
Techno Electric & Engineering Company has partnered with Indigrid to collaboratively undertake development of two of the indigrid’s Greenfield Interstate Transmission System (ISTS) projects and signed the Securities Subscription Cum Shareholders Agreement (SSSHA).
Ipca Laboratories has launched Diulcus, a novel product aimed at addressing the challenges of Diabetic Foot Ulcer (DFU) in the Indian market. Diulcus, developed by NovaLead Pharma, a pioneer in drug repurposing, represents a significant advancement in the management of DFU. The product has received approval from the Central Drugs Standard Control Organization (CDSCO) and was partially funded by the Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: